On Saturday, March 24th, between the hours of 8:00AM ET and 4:00PM ET, we will be undergoing a planned service upgrade. During this time period you will not be able to login, register for an event, or make a purchase via the website. We appreciate your patience, and apologize for any inconvenience this may cause.


Neuroprotective Agents

Edited by Edited by William Slikker, Jr. (National Center for Toxicological Research/FDA, Jefferson, Arkansas), Russell J. Andrews (NASA Ames Research Center, Moffett Field, California), and Bruce Trembly (Veterans Affairs Medical Center, Togus, Maine)
Explore the Table of Contents
Neuroprotective Agents

Published: December 2007

Volume 1122

Learn More

Topics covered in this volume of the proceedings of the Eighth International Neuroprotection Society Meeting include the following clinical implications of neuroprotection (e.g., intensive care and comorbidities; anesthesia hazards) opportunities for neuroprotection; resistance to cell death; nanotechnology; neuroprotection in spinal cord injury; and global brain injury.